i&i Biotech Fund
Investor profile
Investment firm
i&i Biotech Fund has backed 6 European tech companies across 6 funding rounds between 2022 and 2026, joining rounds totalling €35M. Most active in Healthtech and AI. Data as of Nov 2026.
Deals
6
distinct rounds
Companies
6
backed
Active span
2022–2026
5 yrs
Total round €
€35M
sum of rounds joined
Deals by year
distinct rounds / yeari&i Biotech Fund — deals by year — interactive chart.
Data table
| i&i Biotech Fund — deals by year | |
|---|---|
| 2022 | 2 |
| 2023 | 2 |
| 2026 | 2 |
Top sectors
by dealsi&i Biotech Fund — top sectors — interactive chart.
Data table
| i&i Biotech Fund — top sectors | |
|---|---|
| Healthtech | 5 |
| AI | 1 |
Stages
by dealsi&i Biotech Fund — stages — interactive chart.
Data table
| i&i Biotech Fund — stages | |
|---|---|
| Series A | 3 |
| Seed | 2 |
| Other | 1 |
Countries
by dealsi&i Biotech Fund — countries — interactive chart.
Data table
| i&i Biotech Fund — countries | |
|---|---|
| Netherlands | 2 |
| UK | 2 |
| Austria | 1 |
| Czech Republic | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Oost NL2
- aws Gründungsfonds II1
- DBW1
- Demcon Investment1
- DOMiNO Ventures1
- Dutch Government1
- Future Planet Capital1
- Innovation Investment Capital1
- InnovationQuarter1
- Invest AG1
- Kadmos Capital1
- KHAN Technology Transfer Fund I1
- Novalis Biotech1
- Pace Ventures1
- PhotonDelta1
- Takeda Ventures1
- Tensor Ventures1
- UK Innovation & Science Seed Fund1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enzyre | Netherlands | 1 | €12M |
| Antiverse | UK | 1 | €8.0M |
| Delta Diagnostics | Netherlands | 1 | €5.3M |
| HeartBeat.bio | Austria | 1 | €4.5M |
| Ternary Therapeutics | UK | 1 | €4.2M |
| CasInvent | Czech Republic | 1 | €1.3M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Enzyre | Series A | €12M | 2022-11 |
| Antiverse | Series A | €8.0M | 2026-03 |
| Delta Diagnostics | Series A | €5.3M | 2023-05 |
| HeartBeat.bio | Seed | €4.5M | 2023-11 |
| Ternary Therapeutics | Seed | €4.2M | 2026-03 |
| CasInvent | Other | €1.3M | 2022-09 |